Designing focused, tailored and prioritized HIV and viral hepatitis interventions for people who use drugs

UNODC-WHO lunch-time session
Insights zone 3 (I3)
In programme
Wednesday, 23 November, 2022 - 12:20 to 13:10
View presentations

About

This event will seek primarily to give an overview of recent advances in opioid agonist treatment (OAT) and to introduce the WHO Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations and the UNODC-WHO Operational tool for establishing and delivering evidence-based, high-quality opioid agonist therapy services in low- and middle-income countries.

Light lunch will be served.

Chair

Kastelic
Andrej
  • Head,
  • Center for Treatment of Drug Addiction (CTDA), University Psychiatric Clinic Ljubljana,
  • Slovenia

Type

Keywords

Presentations

Wednesday, 23 November

12:20
Oral presentation

1. Community perspective on access to harm reduction

12:20 to 13:10
Insights zone 3 (I3)
Judy Chang
Oral presentation

2. Documenting Egypt’s adoption and upcoming rollout of OAT

12:20 to 13:10
Insights zone 3 (I3)
Raghda Algamil
Oral presentation

3. Introducing the WHO Consolidated guidelines for key populations

12:20 to 13:10
Insights zone 3 (I3)
Annette Verster
Oral presentation

4. Introducing the UNODC-WHO OAT Operational tool and training package

12:20 to 13:10
Insights zone 3 (I3)
Monica Ciupagea
View the programme